Pharmacies refuse to sell potent psychotropic drugs due to strict controls and regulated prices. I noticed this RBC. At the same time, the Ministry of Health stated that enhanced control does not interfere with the sales of drugs.
The reduction of potent psychotropic drugs subject to subject-quantitative accounting, as RBC writes, is evidenced by data from the online pharmacy aggregator Megapteka (includes more than 10 thousand points) and the Honest Sign application. In total, about 20 potent narcotic drugs are registered in Russia. At least eight of them have accessibility issues.
On November 17, the anti-epileptic drug Frizium from the French company Sanofi was in only 56 pharmacies throughout Russia, and in Moscow – in only two pharmacies. 150 pharmacies had its analogue “Klobazam” from the Moscow Endocrine Plant. The Megapteka service showed the complete absence of these drugs in several regions, including Moscow.
The tranquilizer “Zolomax” from the Latvian company Grindex was in ten pharmacies in the Novosibirsk region, in nine in the Sverdlovsk region. The drug was completely absent in the Voronezh and Tambov regions. Its Russian analogue “Alprazol” from JSC “Organika” in the Tambov region was in only three pharmacies.
The press service of the Ministry of Health stated that pharmacy chains themselves form the assortment, with the exception of drugs included in the minimum assortment. The Ministry of Health believes that the requirements for drugs subject to subject-quantitative accounting “are not an obstacle to their sale as part of the normal activities of pharmacies.”
From September 1, the rules for the sale of pharmaceutical substances and preparations containing narcotic drugs have become more stringent. When selling each such medicine, pharmacies must provide the labeling system with details of the prescription received from the buyer.
To sell such drugs, pharmacies need a special permit for the circulation of narcotic drugs, psychotropic substances and their precursors – a license must be available for each point of sale. Such medicines are subject to subject-quantitative accounting; they must be stored in separate rooms in special safes. The alarm system must be equipped with an emergency call to the Russian Guard. For violations of the rules for the circulation of such drugs, a pharmacy can be fined up to 200 thousand rubles.
Earlier, as Kommersant found out, Russian motorists found a way to return the rights that they had been deprived of for driving “under medication.” Last year, the Constitutional Court banned the punishment of drivers for driving under the influence of potent drugs. The judges indicated that a corresponding norm should appear in the Administrative Code, and a specific list of drugs incompatible with driving should appear in the legislation.
Read more about this “Motorists have found a magic pill”.